Survival rates vary due to large individual differences. Typically, the five-year survival rate for acute myeloid leukemia is around 50% to 90%.
The survival rate of AML is closely related to the type of disease, treatment plan, and severity of the disease.
1. Among the many types of AML, type m3 has a high survival rate of 90%. In contrast, the survival rate of other types of myeloid leukemia is relatively low, only 50%, so the survival rate of this disease is within the range of 50% to 90%.
2. AML is a malignant clonal blood disease that causes infections, bleeding, anemia, and other problems, and the disease progresses rapidly. Without treatment, the average life expectancy is often only about 3 months, so it should be treated with caution.
Specific acute myeloid leukemia treatment medications include cytarabine, azacitidine, vinblastine, decitabine, zorubicin, desmethoxyzorubicin, and hypertriglycerides.
In summary, acute myeloid leukemia is more serious, so many patients have greater psychological pressure, it is recommended to adjust the mind. Secondly, we must not listen to the prescription, blind treatment, to follow the doctor’s advice, under the guidance of the physician to receive regular treatment.